✦ LIBER ✦

Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acid

✍ Scribed by James R. Berenson; Ori Yellin; John Crowley; Adel Makary; Donald S. Gravenor; Hank H. Yang; Gargi H. Upadhyaya; Ian W. Flinn; Harry Staszewski; Natasha M. Tiffany; Shamel Sanani; Charles M. Farber; Neil Morganstein; Vanessa Bolejack; Youram Nassir; James D. Hilger; Ashkan Sefaradi; Albert Shamouelian; Regina A. Swift

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 353 KB
Volume: 86
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.21912

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term efficacy and safety of zoledro

Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma : A randomized, double-blind, multicenter, comparative trial

✍ Lee S. Rosen; David Gordon; Mary Kaminski; Anthony Howell; Andrew Belch; John Ma 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

## Abstract ## BACKGROUND The goal of the current study was to compare the long‐term (25‐month) safety and efficacy of zoledronic acid with pamidronate in patients with bone lesions secondary to advanced breast carcinoma or multiple myeloma. ## METHODS Patients (__n__ = 1648) were randomized to